Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.925 | 0.080 | 2 | 214780740 | missense variant | C/G;T | snv | 0.54 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 2007 | 2013 | |||||||
|
0.776 | 0.160 | 2 | 214752454 | missense variant | C/G;T | snv | 1.5E-02 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 2006 | 2012 | |||||||
|
0.776 | 0.160 | 2 | 214752454 | missense variant | C/G;T | snv | 1.5E-02 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.020 | 1.000 | 2 | 2005 | 2006 | |||||||
|
0.851 | 0.080 | 2 | 214771070 | intron variant | T/C | snv | 0.16 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2016 | 2019 | |||||||
|
0.851 | 0.080 | 2 | 214771070 | intron variant | T/C | snv | 0.16 |
|
Neoplasms; Nervous System Diseases | 0.020 | 1.000 | 2 | 2016 | 2019 | |||||||
|
2 | 214781426 | stop gained | G/A;C | snv | 8.0E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.700 | 1.000 | 2 | 2016 | 2017 | |||||||||
|
1.000 | 0.080 | 2 | 214780559 | splice donor variant | C/T | snv | 4.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 2 | 2010 | 2012 | |||||||
|
1.000 | 0.040 | 2 | 214789163 | intron variant | T/A;C | snv |
|
Neoplasms | 0.800 | 1.000 | 2 | 2009 | 2012 | ||||||||
|
2 | 214792327 | stop gained | G/A;T | snv | 8.0E-06 | 1.4E-05 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.700 | 1.000 | 2 | 2013 | 2016 | ||||||||
|
0.925 | 0.200 | 2 | 214797118 | splice acceptor variant | C/A;T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 2 | 2010 | 2012 | ||||||||
|
0.827 | 0.120 | 2 | 214809500 | missense variant | G/A | snv | 0.38 | 0.33 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
|
0.827 | 0.120 | 2 | 214809500 | missense variant | G/A | snv | 0.38 | 0.33 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
|
0.827 | 0.120 | 2 | 214809500 | missense variant | G/A | snv | 0.38 | 0.33 |
|
Neoplasms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
|
1.000 | 0.040 | 2 | 214762673 | intron variant | A/G | snv | 0.42 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2009 | 2009 | |||||||
|
1.000 | 0.080 | 2 | 214728724 | stop gained | C/T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||||||
|
1.000 | 0.040 | 2 | 214754055 | intron variant | A/G | snv | 0.31 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2009 | 2009 | |||||||
|
2 | 214745749 | missense variant | T/C | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
2 | 214745749 | missense variant | T/C | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.925 | 0.120 | 2 | 214728728 | missense variant | C/T | snv | 1.7E-03 | 1.5E-03 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||||
|
0.925 | 0.120 | 2 | 214728728 | missense variant | C/T | snv | 1.7E-03 | 1.5E-03 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.710 | 1.000 | 1 | 2005 | 2005 | ||||||
|
0.925 | 0.120 | 2 | 214728728 | missense variant | C/T | snv | 1.7E-03 | 1.5E-03 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||||
|
1.000 | 0.080 | 2 | 214767643 | stop gained | G/T | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.700 | 1.000 | 1 | 2008 | 2008 | ||||||||
|
1.000 | 0.040 | 2 | 214730921 | non coding transcript exon variant | C/T | snv | 0.30 | 0.26 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2009 | 2009 | ||||||
|
0.882 | 0.080 | 2 | 214778776 | intron variant | C/T | snv | 0.16 |
|
Neoplasms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.882 | 0.080 | 2 | 214778776 | intron variant | C/T | snv | 0.16 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 |